Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Kassotis

Clinical Cardiac Electrophysiology Riverhead, NY Medical Doctor

NPI 1598759003 CMS profile 299734

951 Roanoke Ave, Riverhead, NY 11901

Open in the dashboard

General payments

$255,838

264 records reported · program years 2019–2025

Research payments

$475

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$223,352 paid to institutions, not to them · program years 2019–2025

Through program year 2025, John Kassotis of Riverhead, NY is reported in the CMS Open Payments database as having received $255,838 across 264 general payments and $475 in research payments paid to them. Separately, studies naming them as principal investigator received $223,352 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,817 10
2024 General $26,557 35
2023 General $20,099 28
2022 General $51,551 38
2021 General $41,189 32
2021 Research $475 1
2020 General $25,157 27
2019 General $85,468 94

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Kassotis
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to John Kassotis were reported at $5,817. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year John Kassotis Clinical Cardiac Electrophysiology median Middle half National median
2019 $85,468 $2,361 $585–$8,260 $163
2020 $25,157 $993 $247–$4,351 $114
2021 $41,189 $1,185 $326–$4,739 $132
2022 $51,551 $2,073 $554–$6,789 $149
2023 $20,099 $2,568 $759–$8,159 $160
2024 $26,557 $2,557 $703–$7,403 $164
2025 $5,817 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $119,093 87 payments
  2. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $66,919 66 payments
  3. CVRx, Inc. $45,714 50 payments
  4. AstraZeneca Pharmaceuticals LP $17,989 23 payments
  5. AltaThera Pharmaceuticals LLC $2,577 4 payments
  6. Medtronic Vascular, Inc. $1,670 13 payments
  7. Respicardia, Inc. $573 2 payments
  8. Medtronic, Inc. $512 4 payments
  9. Abbott Laboratories $406 6 payments
  10. Boston Scientific Corporation $197 2 payments
  11. Other $189 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $164,570 99 payments
  2. Consulting Fee $46,275 29 payments
  3. Travel and Lodging $26,948 54 payments
  4. Honoraria $14,500 8 payments
  5. Food and Beverage $3,540 73 payments
  6. Education $5 1 payment
Products named General payments · program years 2019–2025
  1. XARELTO $119,088 86 payments
  2. LifeVest $66,919 66 payments
  3. Barostim Neo System $45,714 50 payments
  4. FARXIGA $17,724 18 payments
  5. Sotalol Hydrochloride $2,577 4 payments
  6. MICRA $1,642 5 payments
  7. remede System $573 2 payments
  8. TYRX $355 2 payments
  9. AVVIGO Guidance System $197 2 payments
  10. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $172 3 payments
  11. Other $834 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $475 1 payment

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$159,620

Medicare's payments for the services billed

Medicare patients

765

Average age 78

Services billed

2,599

338 women, 427 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 62%
Arthritis 50%
Heart failure 38%
Diabetes 36%
Chronic kidney disease 28%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $13,449
$13,449 — —
Sotalol Hydrochloride
  • AltaThera Pharmaceuticals LLC $2,074
$2,074 — —
RYBELSUS
  • Novo Nordisk Inc $11
$11 — —
Ozempic
  • Novo Nordisk Inc $11
$11 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

265 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record